Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Grant of share options to primary insiders in NRC Group ASA

On 15 March 2021, the following primary insiders in NRC Group ASA were granted share options: Henning Olsen, CEO, has been granted 20,000 share options. Following the grant, Henning Olsen holds 30,000 share options and 92,773 shares in NRC Group ASA. Dag Fladby, CFO, has been granted 15,000 share options. Following the grant, Dag Fladby holds 97,500 share options and 70,659 shares in NRC Group ASA. Harri Lukkarinen, EVP and MD NRC Finland, has been granted 42,000 share options. Following the grant, Harri Lukkarinen holds 49,500 share options and 10,429 shares in NRC Group ASA.

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Nordea Bank AbpStock exchange release – Major shareholder announcements15 March 2021 at 21.00 EET Nordea Bank Abp has on 15 March 2021 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights has fallen below the threshold of 5 per cent on 12 March 2021. According to the notification, the total number of Nordea Bank Abp’s shares and voting rights held directly or through financial instruments by BlackRock, Inc. and its funds was below 5 per cent on 12

Asarina Pharma AB (publ) Annual Report 2020 released

Asarina Pharma CEO Peter Nordkild: “2020 and early 2021 have seen new research and additional data confirming and consolidating the efficacy and potential of our flagship compound Sepranolone. As we continue forward into an eventful 2021, we remain confident of the significant clinical relevance of Allopregnanolone, and the ability of our flagship compound Sepranolone to suppress Allopregnanolone’s negative, often devastating effects.”FINANCIAL HIGHLIGHTS · R&D expenses remained at 2019 level reflecting strict cost control · Staff costs declined following headcount reduction ·

Issue and repurchase of series C shares for share saving program

Lund, Sweden, 18:00 CET, 15 March 2021 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, has pursuant to the authorization granted by the annual general meeting on 19 May 2020, through a resolution by the board of directors of BONESUPPORT HOLDING AB (“BONESUPPORT”) resolved to issue and immediately thereafter repurchase 55,000 series C shares. The shares are issued and repurchased in accordance with the share saving program LTI 2020, which was adopted by the annual general meeting on 19 May 2020. Pursuant to the authorization granted by the annual

Lundin Gold Publishes 2020 Annual Filings

VANCOUVER, BC, March 15, 2021 /CNW/ Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG) ("Lundin Gold" or the "Company") announces that the 2020 Annual Filings Document is available for download from the Company’s website: https://lundingold.com/en/investors/quarterly-and-annual-financial-statements/ Additional Information This is information that Lundin Gold is obliged to make public pursuant to the Swedish Markets Act. The information was publicly communicated on March 15, 2021 at 6:00 p.m. CET through the contact persons set out below. View PDF Version 

Nightingale Health Plc comments on the media coverage on its initial public offering

Company Release15 March 2021 at 7.00 p.m. (Finnish time) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Nightingale Health Plc (“Nightingale” or the “Company”) refers to the recent media coverage regarding the subscriptions made in Nightingale’s initial public offering. According to the information given pursuant to market practice to the institutional investors by the Sole

UPM issues its second green bond

(UPM, Helsinki, 15 March 2021 at 19:00 EET) – UPM has successfully issued a new EUR 500 million green bond under its EMTN (Euro Medium Term Note) programme and its Green Finance Framework. The bond matures in March 2031 and pays a fixed coupon of 0.50%. UPM will apply for the bond to be listed on the Irish Stock Exchange plc, trading as Euronext Dublin. Citigroup, BNP Paribas, Danske Bank and Nordea acted as Joint Bookrunners for the transaction. The net proceeds from the bond will be used for financing and/or refinancing of Eligible Projects and Assets under UPM’s Green Finance

Embellence Group publishes prospectus in connection with the listing of the company’s shares on Nasdaq First North Premier Growth Market

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES IN ACCORDANCE WITH APPLICABLE LAW.Embellence Group AB (publ) (”Embellence Group” or the ”Company”), a leading1 House of Brands2 in interior decoration, with a focus on premium brands within wallpaper, textile, rugs and other interior

DEVERSIFY ENTERS DEVELOPMENT AGREEMENT ON NEW MICROSENSORS WITH KTH SPIN-OFF, GATTYINSTRUMENTS

Acetrack is a handheld device that helps you track your ketosis by detecting acetone in your breath. Deversify AB announced today that they have signed a hardware research and development agreement with GattyInstruments AB – a start-up from the Royal Institute of Technology (KTH) with business focused on nano and MEMS technology for sensors. “Microelectromechanical systems, or MEMS, is a technology of manufacturing sensors using microfabrication techniques. Small sensors with high sensitivity and fast response times can be developed with unprecedented accuracy. MEMS technology

Light the flame with Stellaris: Nemesis, available April 15

Newest full feature expansion will give gamers more power than ever beforeSTOCKHOLM - March 15, 2020 -  This weekend Paradox Interactive announced that Nemesis, the newest expansion for Stellaris where players can become the crisis or rally the galaxy against it,  will be available across the galaxy on April 15. With Nemesis, players will determine the fate of a destabilizing galaxy. There are many paths to power, and players can either embrace order and unity as a Galactic Custodian to combat endgame crises - or choose chaos with the Menace option to BECOME the endgame crisis, savoring the

#21-93 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-92 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Thunderful completes acquisition of Headup GmbH and welcomes Dieter Schoeller as Head of Publishing for the group

Thunderful Group AB (“Thunderful”) announces today that the acquisition of Headup GmbH (“Headup”) has been completed. The transaction was announced in a press release on the 24th of February 2021, when it was announced that Thunderful had entered into an agreement to acquire Headup for a total maximum purchase price of EUR 11 million.   Headup, founded in 2009, is an acclaimed publisher and game developer active on all major platforms; consoles, mobile devices and PCs. The head office is located in Düren outside Cologne, Germany. Revenues for 2020 amounted to EUR 4.2 million.

Sustainable Interdental Brush from TePe Awarded Product of the Year in France 2021

TePe Interdental Brushes represent a new generation of health products – high-quality dental care produced with an 80% lower carbon footprint. For this, they received the prestigious Product of the Year Award in the largest independent consumer survey in France.Farah Amri, General Manager of TePe France, said, “We are delighted to receive this award as it recognises that high quality and responsible production can go hand in hand. With our interdental brushes, we offer consumers a sustainable choice for their daily self-care.” The award was granted by a judging panel from Product of the

Olive Jar Digital to target private sector following £6m investment by IW Capital

· Olive Jar Digital is already established within public sector thanks to contracts with NHS and Department for Education · Founders will remain following acquisition by IW Capital to guide the business · Shawbrook Bank supported the investment via £1.5m leverage loanLONDON: 15/03/21 Award winning digital consultancy, Olive Jar Digital, is preparing for growth following a significant £6m investment by IW Capital. Northampton-based Olive Jar specialise in digital transformation projects, helping businesses move away from laborious, manual and paper-based processes. Utilising a

Updated information concerning Net Trading Group NTG AB (publ) enters into an agreement to acquire Rock Energy Group Limited

In relation to the information published earlier today, 15.3.21, on that the board of Net Trading Group NTG AB (‘NTG’) and the board of Rock Energy Group Limited (‘Rock Energy’ and / or ‘REG’) has signed an agreement to acquire REG, the attachment on Rock Energy is updated and includes key financials on p.12 on Rock Energy. The acquisition is part of Net Trading Group's vision to create a profitable and innovative ESG company with focus on green and sustainable energy.  For further information, please contact: Morten Revill, Chairman of Net Trading Group NTG AB (publ)Telefon:

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    15 March 2021 at 17:00 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Vansbro Consulting Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Paananen, Jokke Position: Member of the Board Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20210315111107_2 __________________________

Correction - Change in number of shares and votes in Risk Intelligence A/S

Correction of the previously disclosed press release since the information is not regarded as insider information. The MAR-label has therefore been removed from the press release.The total number of shares and votes in Risk Intelligence A/S, reg. no. 27475671 (“Risk Intelligence”), has changed last week consequent upon the directed issue of 1,467,050 new shares to institutional, professional and private investors. Subsequent to the directed share issue, the total number of shares and votes in Risk Intelligence as of 15 March 2021 is 10,577,430. Through the directed share issue, Risk

Support grows for USD 5 billion research fund to decarbonise shipping as Denmark joins major shipping nations

Washington, D.C./Brussels/ Singapore, 15 March 2021 - The proposal to create a USD 5 billion USD International Maritime Research and Development Board (IMRB) was submitted to the UN’s International Maritime Organisation (IMO) on the 10[th] of March 2021 by Georgia, Greece, Japan, Liberia, Malta, Nigeria, Palau, Singapore, and Switzerland. Denmark now joins as a co-sponsor, and we expect several other nations to voice their support for the proposal at the next meeting of the IMO Marine Environment Protection Committee in June.“The sponsoring nations have done a very thorough job, mapping out

Orkla ASA: The Board of Directors' proposal to Orkla's General Meeting

The Annual General Meeting of Orkla ASA will be held as a digital venue on Thursday 15 April 2021 at 12:30 p.m.At a meeting on 15 March 2021 the Board of Directors decided to submit the following resolution to Orkla's General Meeting: The Board of Directors proposes an ordinary dividend for 2020 of NOK 2.75 per share. See separate announcement regarding key information relating to the cash dividend. Orkla's Annual Report 2020 will be released on 19 March 2021.   Orkla ASA Oslo, 15 March 2021   Ref.: Group Director, Corporate Communications and Corporate Affairs

Orkla ASA: Key information relating to the cash dividend

At a meeting on 15 March 2021, the Board of Directors decided to propose for the annual general meeting an ordinary dividend for 2020 of NOK 2.75 per share.Dividend amount: 2.75 per share Declared currency: NOK Last day including right: 15 April 2021 Ex-date: 16 April 2021 Record date: 19 April 2021 Payment date: 26 April 2021 Date of approval: 15 April 2021   Orkla ASA Oslo, 15 March 2021   Ref.: Group Director, Corporate Communications and Corporate Affairs Håkon Mageli Tel.: +47 92 84 58 28 SVP Investor Relations Kari Lindtvedt Tel.: +47

EQL in-license seven products for Denmark

EQL Pharma has today purchased seven (7) licenses, of which five (5) are exclusive, for products on the Danish market. The licenses already have marketing authorizations in Denmark. "These are niche generics that complement our portfolio well and fit into our strategy for the Nordic region and Denmark," says Christer Fåhraeus, CEO of EQL Pharma. The total turnover in the markets where these products compete is slightly more than 50mDKK (2020). All products are prescription-only and have between one and three active competitors, excluding EQL.The sales start is expected in EQL Pharma’s first

There are no items matching the current filter
There are no more items matching the current filter
Back to top